Leo I. Gordon MD
Clinical updates in Hodgkin lymphoma and non-Hodgkin lymphoma (NHL) have continued to evolve the space, such as moving away from toxic regimens and more toward a personalized or chemotherapy-free approach, explained Leo I. Gordon, MD.
State of the Science Summit™ on Hematologic Malignancies, Gordon discussed these recent updates in Hodgkin lymphoma and NHL and pointed to research on the horizon.
OncLive: What are the key changes in Hodgkin lymphoma and NHL treatment?
: The [2 main] issues in Hodgkin lymphoma still remain: first, what to do with PET scans and how to improve results based on PET scans, [and second, answering] the question, “Where are we going in the future?”
... to read the full story